Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions
- DS Stage I Plasma Cell Myeloma
- DS Stage II Plasma Cell Myeloma
- DS Stage III Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
Interventions
- DRUG: Bortezomib
- RADIATION: Total-Body Irradiation
- DRUG: Melphalan
- PROCEDURE: Autologous Bone Marrow Transplantation
- PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
- PROCEDURE: Peripheral Blood Stem Cell Transplantation
- OTHER: Laboratory Biomarker Analysis
Sponsor
Mayo Clinic
Collaborators